ACP Suggests First-Line Obesity Drugs

• by Kathryn Wighton

• June 16, 2026

Tirzepatide’s cardiovascular effects in clinical practice

Investigators compared cardiovascular outcomes with tirzepatide and a placebo proxy in patients with type 2 diabetes and established atherosclerotic cardiovascular disease.

• by Kathryn Wighton

• August 28, 2026

• 4 min

Medical Oddities: Dogs share our mortality markers

The bond with dogs runs deeper, the brain enjoys a good sweat, love on screen gets real, and tea carries a little more weight.

• by Teraya Smith

• September 2, 2026

• 5 min

Preoperative Factors Associated with Weight Loss and Recurrent Weight Gain after Bariatric Surgery: A Longitudinal Study in a UK Public Healthcare Setting

• by Luqman Naim Bin Aizan, Akheel A. Syed, Bilal Alkhaffaf

• August 28, 2026